Metfendrazine
![]()  | |
| Clinical data | |
|---|---|
| Routes of administration  | Oral | 
| ATC code | none | 
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
  | |
| CAS Number | 3734-26-7 | 
| PubChem (CID) | 19516 | 
| ChemSpider | 18390 | 
| Chemical and physical data | |
| Formula | C10H16N2 | 
| Molar mass | 164.25 g/mol | 
Metfendrazine (HM-11, MO-482), also known as methphendrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class.[1][2] It was investigated as an antidepressant, but was never marketed.
See also
References
- ↑ Miquel, J.; Mijan, C. D. (1962). "Metfendrazine, a new inhibitor of monoamine oxidase". Arch. Inst. Farmacol. Exp. (Madrid). 14: 47–59.
 - ↑ Kothari NJ, Saunders JC, Kline NS, Griffen JA (October 1960). "A comparison of perphenazine, proketazine, nialamide and MO-482 in chronic schizophrenics". The American Journal of Psychiatry. 117: 358–60. PMID 13753478.
 
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
